This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nickenig, G. Articles by Böhm, M. Search for Related Content PubMed PubMed Citation Articles by Nickenig, G. Articles by Böhm, M. Social Bookmarking                         What's this?

Acute effects of ACE inhibition on coronary endothelial dysfunction

Klinik und Poliklinik Innere Medizin , Universität des Saarlandes, Homburg, Germany, nickenig@ med-in.uni-sb.de

Alexander Stäblein

Klinik und Poliklinik Innere Medizin , Universität des Saarlandes, Homburg, Germany

Sven Wassmann

Klinik und Poliklinik Innere Medizin , Universität des Saarlandes, Homburg, Germany

Christoph Wyen

Klinik und Poliklinik Innere Medizin , Universität des Saarlandes, Homburg, Germany

Cornelius Müller

Klinik und Poliklinik Innere Medizin , Universität des Saarlandes, Homburg, Germany

Michael Böhm

Klinik und Poliklinik Innere Medizin , Universität des Saarlandes, Homburg, Germany

The prerequisite of atherosclerosis, endothelial dysfunction, is characterised by impaired endothelium-dependent vasodilation caused by the reduced bioavailibility of nitric oxide (NO). In order to assess the role of acute ACE inhibition in this setting, coronary arterial endothelial function was quantified following acute intracoronary administration of the angiotensin-converting enzyme (ACE) inhibitor quinapril. Twenty-one patients with non-limiting coronary artery disease were studied before and after acute intracoronary administration of 10 mg quinapril. Nine patients received pre-treatment with the angiotensin AT₁-receptor antagonist losartan (2x50 mg, p.o.). Coronary cross-sectional diameter was measured via quantitative angiography and microvascular reaction was investigated by intracoronary Doppler flow measurement during intracoronary infusion of 0.1 to 10 µmol/l acetylcholine. Quinapril acutely improved endothelial dysfunction on the macro- as well as the microvascular level. Losartan did not alter macrovascular function but facilitated microvascular endothelial function. Acute quinapril application led to no further improvement of endothelial dysfunction in patients pre-treated with losartan.

Acute quinapril infusion improved endothelial function in patients with coronary heart disease. Treatment with the AT₁-receptor antagonist losartan led to a slight improvement in microvascular endothelial function, but pre-treatment with losartan blunted the vascular effect of quinapril, suggesting that the combination of ACE inhibition and AT₁-receptor antagonism may not exert a synergistic benefical impact on the coronary vasculature.

Key Words: ACE inhibitors • endothelial function • coronary arteries • AT1-receptor antagonists

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 4, 361-364 (2000)
DOI: 10.3317/jraas.2000.067


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF]

				A. Ceriello, R. Assaloni, R. Da Ros, A. Maier, L. Piconi, L. Quagliaro, K. Esposito, and D. Giugliano Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients Circulation, May 17, 2005; 111(19): 2518 - 2524. [Abstract] [Full Text] [PDF]

				C. P. Tiefenbacher, S. Friedrich, T. Bleeke, C. Vahl, X. Chen, and F. Niroomand ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1425 - H1432. [Abstract] [Full Text] [PDF]